IBRUTINIB WITH RITUXIMAB (IR) AND SHORT COURSE R‐HYPERCVAD/MTX IS VERY EFFICACIOUS IN PREVIOUSLY UNTREATED YOUNG PTS WITH MANTLE CELL LYMPHOMA (MCL). (12th June 2019)

• Record Type: Journal Article
• Authors: Wang, M.; Jain, P.; Zhang, S.; Nomie, K.; Wang, L.; Oriabure, O.; Nogueras Gonzales, G.; Zhang, L.; Wagner‐Bartak, N.; Hagemeister, F.; Samaniego, F.; Westin, J.; Lee, H.J.; Nastoupil, L.; Ok, C.; Kanagal‐Shamanna, R.; Chen, W.; Thirumurthi, S.; Santos, D.; Badillo, M.; Fayad, L.; Neelapu, S.; Fowler, N.; Romaguera, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 42
• Page End: 43
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.12_2629
• Languages: English
• ISSNs: 0278-0232